Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Protiveris is a biotechnology company that specialized in the development of high-sensitivity protein analysis platforms using nanomechanical sensors. The company's core technology, the VeriScan platform, utilized micro-cantilever arrays to enable label-free detection and characterization of proteins and other biomolecules. This system was designed to provide real-time, multiplexed analysis for applications in drug discovery, proteomics research, and clinical diagnostics. By eliminating the need for fluorescent or radioactive labels, the technology aimed to simplify workflows and improve the accuracy of biomarker identification. Although the company is currently inactive, its innovations in nanotechnology-based biosensing were significant in the field of proteomics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Protiveris.